Case Remain for Bal...
Health Care: Drugs
Sequenom Inc. (SQNM: NASDAQ)
$4.11 0.01 | 0.24%
05/20/13 - 04:00 PM ET
1.55M / 2.80M
Vol / Avg. Vol:4.08 / 4.10
Open / Prev. Close:4.06 - 4.15
Today's Range:2.65 - 5.36
52 Wk Range:-12.74%
Performance YTD:TheStreet Rating:
Portfolios with SQNM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserMark
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- Contributor10 Most Shorted Stocks in B...
Latest SQNM Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 04.04.13 | 01:04 pm
- 'Mad Money' Lightning Round: I Like Winnebago. 03.16.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 03.15.13 | 07:03 pm
- Insiders Trading RSG, STAA, RT, SQNM 08.03.12 | 10:08 am
- Sequenom's CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 11:07 pm
- 5 Biotech Stocks Under $10 Set to Soar 07.19.12 | 11:07 am
- 4 Biotech Stocks Under $10 Moving Higher 07.12.12 | 01:07 pm
- 8 Stocks Under $10 Loved by the Bulls 06.19.12 | 02:06 pm
- Sequenom Stock Hits New 52-Week Low (SQNM) 06.04.12 | 10:06 am
- Salesforce.com: After-Hours Headlines 05.17.12 | 06:05 pm
Press Releases for SQNM
- Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference - PR Newswire 05.08.13 | 07:05 am
- Sequenom, Inc. Announces Date Of First Quarter 2013 Financial Results And Conference Call - PR Newswire 04.25.13 | 07:04 am
- Sequenom CMM Achieves Milestone Of 100,000 MaterniT21â¿¢ Plus Tests Processed - PR Newswire 04.16.13 | 07:04 am
- Sequenom, Inc. Announces The Availability Of Heredi-Tâ¿¢ Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM - PR Newswire 03.21.13 | 07:03 am
- Sequenom Announces Participation At The 25th Annual Roth Conference - PR Newswire 03.15.13 | 02:03 pm
- Sequenom Announces Participation At The Barclays Global Healthcare Conference - PR Newswire 03.05.13 | 07:03 am
- Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call - PR Newswire 02.20.13 | 07:02 am
- Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities - PR Newswire 02.04.13 | 07:02 am
- Sequenom Announces Preliminary 2012 Operational Highlights - PR Newswire 01.06.13 | 11:01 pm
- Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference - PR Newswire 01.02.13 | 07:01 am
Partner Headlines for SQNM
- Market Wrap for Friday, March 8: Stocks Close Out Strong Week WIth More Gains - Benzinga 03.08.13 | 04:03 pm
- RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November - Benzinga 12.01.12 | 01:12 pm
- Luminex Misses Ests., Trims Outlook - Analyst Blog - Zacks 10.30.12 | 10:10 am
- Luminex Remains Neutral - Analyst Blog - NASDAQ 09.17.12 | 08:09 pm
- Luminex Wins Technology Award - Analyst Blog - NASDAQ 09.07.12 | 04:09 pm
- 4 Highly Liquid Small Cap Healthcare Stocks Set For Growth - Seeking Alpha 09.04.12 | 09:09 am
- Weekly CFO Buys Highlight: PTSX, MTG, IRDM, SQNM, FNFG, LF - GuruFocus 08.13.12 | 11:08 am
- Luminex Wins DTRA Contract - Analyst Blog - Zacks 08.10.12 | 05:08 pm
- Sequenom Inc. CEO Harry Hixson Bought 50,000 Shares - GuruFocus 08.03.12 | 01:08 pm
- Healthcare Biz Review: Sequenom DENIED Injunction, Qiagen WINS FDA Approval - Wall St. Cheat Sheet 07.07.12 | 12:07 pm
